Federal
COVID–19 Medical Debt Collection Relief Act of 2021
Source: Congress.gov ·
1,430 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
117TH CONGRESS
1ST SESSION
S. 355
To provide immediate relief for patients from certain medical debt collection
efforts during and immediately after the COVID–19 public health emergency.
IN THE SENATE OF THE UNITED STATES
FEBRUARY 22, 2021
Mr. VAN HOLLEN (for himself, Mr. MERKLEY, Mr. BROWN, and Mr.
BLUMENTHAL) introduced the following bill; which was read twice and re-
ferred to the Committee on Health, Education, Labor, and Pensions
A BILL
To provide immediate relief for patients from certain medical
debt collection efforts during and immediately after the
COVID–19 public health emergency.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘COVID–19 Medical
4
Debt Collection Relief Act of 2021’’.
5
SEC. 2. RELIEF FROM MEDICAL DEBT COLLECTION.
6
(a) DEFINITIONS.—In this section:
7
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
2
•S 355 IS
(1) COVERED PERIOD.—The term ‘‘covered pe-
1
riod’’ means the period beginning on February 1,
2
2020, and ending on the date that is the later of—
3
(A) the end of the incident period with re-
4
spect to the emergency involving Federal pri-
5
mary responsibility determined to exist by the
6
President under section 501(b) of the Robert T.
7
Stafford Disaster Relief and Emergency Assist-
8
ance Act (42 U.S.C. 5191(b)) with respect to
9
the coronavirus disease 2019 (COVID–19); or
10
(B) 18 months after the date of enactment
11
of this Act.
12
(2) COVERED PROVIDER.—The term ‘‘covered
13
provider’’ means any entity or individual that—
14
(A) provides health care services to pa-
15
tients; and
16
(B) has applied for or accepted any Fed-
17
eral funds for COVID–19 health care costs or
18
financial relief, including funds allocated under
19
the Families First Coronavirus Response Act
20
(Public Law 116–127), the CARES Act (Public
21
Law 116–136), or any other Federal law that
22
allocates COVID–19 relief funding.
23
(3) EXTRAORDINARY COLLECTION ACTIONS.—
24
The term ‘‘extraordinary collection actions’’ means
25
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
3
•S 355 IS
the actions described in section 1.501(r)–6(b) of title
1
26, Code of Federal Regulations.
2
(4) MEDICAL DEBT.—The term ‘‘medical debt’’
3
means a debt arising from the receipt of medical
4
services, products, or devices.
5
(5) SECRETARY.—The term ‘‘Secretary’’ means
6
the Secretary of Health and Human Services.
7
(b) SUSPENSION
OF COLLECTION ACTIVITIES.—A
8
covered provider and agents operating on behalf of covered
9
providers shall suspend all extraordinary collection actions
10
relating to the collection of a medical debt relating to a
11
patient during the covered period.
12
(c) SUSPENSION OF REPAYMENT PLANS.—
13
(1) IN GENERAL.—With respect to a patient
14
who has entered into a repayment plan with a cov-
15
ered provider relating to a medical debt, such pro-
16
vider shall take the following actions:
17
(A) Include in patient billing a notification
18
that repayment plans for medical debt are
19
available upon request.
20
(B) Include in patient billing a notification
21
that any patient who has entered into a repay-
22
ment plan with the provider may request a sus-
23
pension of the payment plan during the covered
24
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
4
•S 355 IS
period, and provide contact information for the
1
patient to make such request.
2
(C) Suspend such repayment plan upon
3
the request of the patient or the patient’s
4
guardian for the duration of the covered period.
5
(D) Ensure the application of reasonable
6
forbearance and repayment options when such
7
repayments resume. Such options may include
8
maintaining the same payment schedule with
9
respect to the medical debt by extending the re-
10
payment period by the same period of time that
11
payments were suspended under this sub-
12
section.
13
(2) GUIDANCE.—Not later than 14 days after
14
the date of enactment of this Act, the Secretary
15
shall issue guidance on best practices for notifying
16
patients of their repayment options, as described in
17
paragraph (1). Such guidance shall include taglines
18
that alert individuals with limited English pro-
19
ficiency (LEP) to the availability of language assist-
20
ance services.
21
(3) INTEREST
AND
FEES.—Interest or fees
22
shall not accrue during the period in which a pay-
23
ment plan is suspended under paragraph (1).
24
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
5
•S 355 IS
(d) APPLICATION OF CERTAIN CONSUMER PROTEC-
1
TIONS.—
2
(1) IN GENERAL.—Medical debt incurred dur-
3
ing the period beginning on February 1, 2020, and
4
ending on the date that is 60 days after the lifting
5
of the state of emergency for COVID–19-related
6
testing and treatment (as determined by the Sec-
7
retary) shall be subject to the following consumer
8
protections:
9
(A) A one-year extension of Federal and
10
State health insurance appeal deadlines, includ-
11
ing the deadlines set forth in section 2719 of
12
the Public Health Service Act (42 U.S.C.
13
300gg–19) and sections 2590.715 through
14
2179 of title 29, Code of Federal Regulations,
15
and the appeal and grievance deadlines for the
16
denials of Medicare or Medicaid claims under
17
titles XVIII and XIX of the Social Security Act
18
(42 U.S.C. 1395 and 1396 et seq.).
19
(B) A prohibition on the accrual and col-
20
lection of fees and interest related to the med-
21
ical debts involved.
22
(C) A prohibition on any extraordinary col-
23
lection
actions
as
described
in
sections
24
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
6
•S 355 IS
1.501(r)–(6)(b) of title 26, Code of Federal
1
Regulations.
2
(2) COVID–19 RELATED TESTING AND TREAT-
3
MENT.—For purposes of paragraph (1), the term
4
‘‘COVID–19-related testing and treatment’’ includes
5
items and services (including in-person or telehealth
6
visits in which such items and services are fur-
7
nished) that are furnished—
8
(A) to an individual who has been diag-
9
nosed with (or after the provision of such items
10
and services is diagnosed with) COVID–19 to
11
treat or mitigate the effects of COVID–19; and
12
(B) to an individual who is presumed by a
13
health care provider to have COVID–19 but is
14
never diagnosed as such.
15
(e) PENALTIES.—Except as provided in this section,
16
a covered provider or its agent that fails to comply with
17
any provision of this section with respect to a patient shall
18
be liable to such patient for damages in an amount equal
19
to the sum of—
20
(1) any actual damages sustained by such pa-
21
tient as a result of such failure to comply;
22
(2) in the case of an action commenced—
23
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
7
•S 355 IS
(A) by an individual, any additional dam-
1
ages as the court may permit, but not to exceed
2
$1,000 for each failure to comply; or
3
(B) by a class of patients—
4
(i) such amount for each named plain-
5
tiff as could be recovered under paragraph
6
(1) and subparagraph (A); and
7
(ii) such amount as the court may
8
allow for all other class members, without
9
regard to a minimum individual recovery,
10
not to exceed the lesser of $2,000,000 or
11
1 percent of the annual net income of the
12
covered provider; and
13
(3) in the case of any successful action under
14
this section, the costs of the action, together with a
15
reasonable attorney’s fee as determined appropriate
16
by the court.
17
Æ
VerDate Sep 11 2014
16:05 Feb 28, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\S355.IS
S355
pamtmann on DSKBC07HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.